Synthetic lethal screening reveals FGFR as one of the combinatorial targets to overcome resistance to Met-targeted therapy.
Kim B, Wang S, Lee JM, Jeong Y, Ahn T, Son DS, Park HW, Yoo HS, Song YJ, Lee E, Oh YM, Lee SB, Choi J, Murray JC, Zhou Y, Song PH, Kim KA, Weiner LM.
Kim B, et al. Among authors: lee e, lee sb, lee jm.
Oncogene. 2015 Feb 26;34(9):1083-93. doi: 10.1038/onc.2014.51. Epub 2014 Mar 24.
Oncogene. 2015.
PMID: 24662823
Free PMC article.